8107 resources
By Version
By realm
Start Prev Rows 4800 - 5000 Next
Package | Version | Identity | Name/Title | Status | Date | Realm | Source(s) |
---|---|---|---|---|---|---|---|
hl7.fhir.us.bfdr | R4 | ValueSet-fertility-enhancing-drug-therapy-artificial-insem | Fertility Enhancing Drug Therapy and Artificial Insemination Value Set | active | 2024-10 | us | sct |
hl7.fhir.us.bfdr | R4 | ValueSet-fetal-death-cause-or-condition | Fetal Death Cause or Condition | active | 2024-10 | us | fhir sct tho |
hl7.fhir.us.bfdr | R4 | ValueSet-fetal-death-time-points | Fetal Death Time Points | active | 2024-10 | us | sct tho |
hl7.fhir.us.bfdr | R4 | ValueSet-fetal-presentations-max | Fetal Presentations - Max | active | 2024-10 | us | fhir sct |
hl7.fhir.us.bfdr | R4 | ValueSet-fetal-presentations | Fetal Presentations | active | 2024-10 | us | sct tho |
hl7.fhir.us.bfdr | R4 | ValueSet-fetal-remains-disposition-method | Fetal Remains Disposition Method | active | 2024-10 | us | sct tho |
hl7.fhir.us.bfdr | R4 | ValueSet-infections-during-pregnancy-live-birth | Infections During Pregnancy Live Birth | active | 2024-10 | us | sct tho |
hl7.fhir.us.bfdr | R4 | ValueSet-informant-relationship-to-mother | Informant Relationship to Mother | active | 2024-10 | us | fhir |
hl7.fhir.us.bfdr | R4 | ValueSet-location-types | Location Types | active | 2024-10 | us | fhir |
hl7.fhir.us.bfdr | R4 | ValueSet-newborn-congenital-anomalies | Newborn Congenital Anomalies | active | 2024-10 | us | sct tho |
hl7.fhir.us.bfdr | R4 | ValueSet-number-previous-cesareans-edit-flags | Number of Previous Cesareans Edit Flags (NCHS) | active | 2024-10 | us | fhir |
hl7.fhir.us.bfdr | R4 | ValueSet-obstetric-procedure-outcome | Obstetric Procedure Outcome | active | 2024-10 | us | sct |
hl7.fhir.us.bfdr | R4 | ValueSet-performed-not-performed-planned | Performed NotPerformed Planned | active | 2024-10 | us | sct |
hl7.fhir.us.bfdr | R4 | ValueSet-pregnancy-report-edit-flags | Pregnancy Report Edit Flags (NCHS) | active | 2024-10 | us | fhir |
hl7.fhir.us.bfdr | R4 | ValueSet-units-of-gestational-age | Units of Gestational Age | active | 2024-10 | us | ucum |
hl7.fhir.us.bfdr | R4 | cigarette-smoking-before-during-pregnancy | Cigarette Smoking Before and During Pregnancy | active | 2024-10 | us | loinc |
hl7.fhir.uv.ichom-breast-cancer | R4 | AgreementResponseVS | Agreement response ValueSet | active | 2023-08 | uv | fhir |
hl7.fhir.uv.ichom-breast-cancer | R4 | AxillaSurgeryVS | Axilla surgery ValueSet | active | 2023-08 | uv | sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | BodyWeightVS | Units of patient's body weight ValueSet | active | 2023-08 | uv | ucum |
hl7.fhir.uv.ichom-breast-cancer | R4 | BreastSurgeryTypeVS | Types of breast surgery ValueSet | active | 2023-08 | uv | fhir tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | ChemoTherapyTypeVS | Type of chemotherapy ValueSet | active | 2023-08 | uv | sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | ComplicationImpactVS | Impact of complication ValueSet | active | 2023-08 | uv | fhir sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | ComplicationTypeVS | Type of complication ValueSet | active | 2023-08 | uv | fhir sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | EducationLevelVS | Education level of patient ValueSet | active | 2023-08 | uv | sct |
hl7.fhir.uv.ichom-breast-cancer | R4 | EstrogenStatusVS | Estrogen receptor status ValueSet | active | 2023-08 | uv | sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | GermlineMutationVS | Germline Mutation ValueSet | active | 2023-08 | uv | sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | GradingVS | Grading of tumor ValueSet | active | 2023-08 | uv | sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | HER2ReceptorStatusVS | HER2 receptor status ValueSet | active | 2023-08 | uv | sct |
hl7.fhir.uv.ichom-breast-cancer | R4 | HistologicalTypeVS | Histological type of the tumor ValueSet | active | 2023-08 | uv | sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | HormonalTherapyTypeVS | Type of hormonal therapy ValueSet | active | 2023-08 | uv | sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | ImplantLocationVS | Location of the implant ValueSet | active | 2023-08 | uv | fhir |
hl7.fhir.uv.ichom-breast-cancer | R4 | InvolvedMarginsReoperationTypeVS | Re-operation due to involved margins ValueSet | active | 2023-08 | uv | fhir sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | LateralityNewCancerVS | Laterality of new cancer ValueSet | active | 2023-08 | uv | sct |
hl7.fhir.uv.ichom-breast-cancer | R4 | LateralityVS | Laterality of breast cancer ValueSet | active | 2023-08 | uv | sct |
hl7.fhir.uv.ichom-breast-cancer | R4 | LocationRadiotherapyVS | The location of radiotherapy ValueSet | active | 2023-08 | uv | sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | MenopausalStatusVS | Menopausal status of patient ValueSet | active | 2023-08 | uv | sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | MolecularProfilingStatusVS | Molecular profiling | active | 2023-08 | uv | fhir |
hl7.fhir.uv.ichom-breast-cancer | R4 | NoYesUnknownVS | Yes, No and Unknown Valueset | active | 2023-08 | uv | tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | PatientEducationVS | Patient Treatment Education ValueSet | active | 2023-08 | uv | fhir |
hl7.fhir.uv.ichom-breast-cancer | R4 | PatientTreatPrefVS | Patient treatment preference ValueSet | active | 2023-08 | uv | fhir sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | ProgesteroneStatusVS | Progesterone receptor status ValueSet | active | 2023-08 | uv | sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | RecommendedTreatmentTypeVS | Recommended treatment types ValueSet | active | 2023-08 | uv | fhir sct |
hl7.fhir.uv.ichom-breast-cancer | R4 | ReconstructionTypeVS | Type of reconstruction surgery ValueSet | active | 2023-08 | uv | fhir tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | RecurrenceMethodVS | Recurrence method ValueSet | active | 2023-08 | uv | fhir sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | RecurrenceVS | Recurrence of neoplasm ValueSet | active | 2023-08 | uv | fhir tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | RelationshipStatusVS | Relationship status of patient ValueSet | active | 2023-08 | uv | tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | ReoperationReasonVS | Reasoncode of the re-operation | active | 2023-08 | uv | sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | ReoperationTypeVS | Type of re-operation | active | 2023-08 | uv | fhir sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | SACQPatientComorbidityHistory | SACQ Patient's comorbidity history ValueSet | active | 2023-08 | uv | sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | SatisfactionResponseVS | Satisfaction response ValueSet | active | 2023-08 | uv | fhir |
hl7.fhir.uv.ichom-breast-cancer | R4 | TNMDistantMetastasesVS | TNM Distant Metastases ValueSet | active | 2023-08 | uv | sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | TNMPrimaryTumorVS | TNM Primary Tumor ValueSet | active | 2023-08 | uv | sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | TNMRegionalNodesVS | TNM Regional Nodes ValueSet | active | 2023-08 | uv | sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | TNMStageGroupVS | Staging Type for Stage Group ValueSet | active | 2023-08 | uv | loinc |
hl7.fhir.uv.ichom-breast-cancer | R4 | TargetedAxillaSurgeryVS | Targeted axilla surgery ValueSet | active | 2023-08 | uv | sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | TargetedTherapyVS | Type of targeted therapy ValueSet | active | 2023-08 | uv | sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | TherapyIntentVS | Intent of therapy ValueSet | active | 2023-08 | uv | sct tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | TreatmentPlanComplianceVS | Observation identifiers for treatment plan non-compliance reason ValueSet | active | 2023-08 | uv | fhir |
hl7.fhir.uv.ichom-breast-cancer | R4 | TreatmentPlanFollowedVS | Real Treatment Plan Followed ValueSet | active | 2023-08 | uv | fhir |
hl7.fhir.uv.ichom-breast-cancer | R4 | TreatmentPlanNotFollowedVS | Treatment Plan Not Followed ValueSet | active | 2023-08 | uv | fhir tho |
hl7.fhir.uv.ichom-breast-cancer | R4 | TreatmentTypeVS | Type of treatments ValueSet | active | 2023-08 | uv | fhir sct tho |
ch.fhir.ig.ch-epr-fhir | R4 | ChPdqmMoreAttriburesRequested | CH PDQm ValueSet More Attributes Requested | active | 2024-10 | ch | oid |
ch.fhir.ig.ch-epr-fhir | R4 | PpqmActorIdentifierType | CH PPQm Actor Identifier Type | active | 2024-10 | ch | ietf |
ch.fhir.ig.ch-epr-fhir | R4 | PpqmConsentIdentifierType | CH PPQm Consent Identifier Type | active | 2024-10 | ch | internal |
ch.fhir.ig.ch-epr-fhir | R4 | PpqmFeedRequestHttpMethod | CH PPQm Feed Request HTTP Method | active | 2024-10 | ch | fhir |
ch.fhir.ig.ch-epr-fhir | R4 | PpqmPolicySetTemplateId | CH PPQm Policy Set Template ID | active | 2024-10 | ch | internal |
ch.fhir.ig.ch-epr-fhir | R4 | PpqmReferencedPolicySetDefaultProvide | CH PPQm Referenced Policy Set for Default Provide (203) template | active | 2024-10 | ch | ietf |
ch.fhir.ig.ch-epr-fhir | R4 | PpqmReferencedPolicySetFullAccess | CH PPQm Referenced Policy Set for Patients (201) and Representative (303) templates | active | 2024-10 | ch | ietf |
ch.fhir.ig.ch-epr-fhir | R4 | PpqmReferencedPolicySetGroupEmergency | CH PPQm Referenced Policy Set for Emergency Access (202) and HCP Group (302) templates | active | 2024-10 | ch | ietf |
ch.fhir.ig.ch-epr-fhir | R4 | PpqmReferencedPolicySetHcpWithDelegation | CH PPQm Referenced Policy Set for Healthcare Professionals with Delegation (304) template | active | 2024-10 | ch | ietf |
ch.fhir.ig.ch-epr-fhir | R4 | PpqmReferencedPolicySetHcpWithoutDelegation | CH PPQm Referenced Policy Set for Healthcare Professionals without Delegation (301) template | active | 2024-10 | ch | ietf |
hl7.fhir.us.qicore | R4 | qicore-medication-dose-type | QICore SNOMED CT Dosage Codes | draft | 2018-08 | us | sct |
hl7.fhir.us.qicore | R4 | qicore-negation-reason | QICore Negation Reason Codes | active | 2018-12 | us | vsac |
hl7.fhir.us.qicore | R4 | qicore-non-negative-event-status | Non-Negative Event Status | active | 2018-12 | us | fhir |
hl7.fhir.us.qicore | R4 | qicore-non-negative-immunization-status | Non-Negative Immunization Status | active | 2018-12 | us | fhir |
hl7.fhir.us.qicore | R4 | qicore-non-negative-medication-admin-status | Non-Negative MedicationAdministration Status | active | 2018-12 | us | tho |
hl7.fhir.us.qicore | R4 | qicore-non-negative-medicationdispense-status | Non-Negative MedicationDispense Status | active | 2018-12 | us | tho |
hl7.fhir.us.qicore | R4 | qicore-non-negative-observation-status | Non-Negative Observation Status | active | 2018-12 | us | fhir |
hl7.fhir.us.qicore | R4 | qicore-non-negative-task-status | Non-Negative Task Status | active | 2018-12 | us | fhir |
hl7.fhir.us.qicore | R4 | qicore-observation-body-position | QICore Observation Body Position | active | 2018-08 | us | sct |
hl7.fhir.us.qicore | R4 | qicore-present-on-admission | QICore Present On Admission Codes | draft | 2021-05 | us | cms |
hl7.fhir.uv.fhirpath | R4 | calendar-units | Calendar Duration Units ValueSet | active | 2024-02 | uv | fhir |
hl7.fhir.uv.fhirpath | R4 | example-expansion | LOINC Codes for Cholesterol in Serum/Plasma | draft | 2015-06 | uv | loinc |
hl7.fhir.us.insurance-card | R4 | C4DICContactTypeVS | C4DIC Contact Type | active | 2024-04 | us | fhir tho |
hl7.fhir.us.insurance-card | R4 | C4DICCopayTypeVS | C4DIC Copay Type | active | 2024-04 | us | fhir |
hl7.fhir.us.insurance-card | R4 | C4DICCoverageClassVS | C4DIC Coverage Class | active | 2024-04 | us | fhir tho |
hl7.fhir.us.insurance-card | R4 | C4DICCoverageIdentifierType | C4DIC Coverage Identifier Type | active | 2024-04 | us | fhir tho |
hl7.fhir.us.insurance-card | R4 | ISOColorVS | C4DIC ISO Color | active | 2024-04 | us | tho |
hl7.fhir.us.pq-cmc-fda | R5 | capsule-classification-category | Capsule Shell Classification Terminology | draft | 2024-10 | us | fhir |
hl7.fhir.us.pq-cmc-fda | R5 | cmc-comp-section-types-vs | eCTD sections Terminology | draft | 2024-10 | us | fhir |
hl7.fhir.us.pq-cmc-fda | R5 | cmc-product-name-types-vs | Product Name Types Terminology | draft | 2024-10 | us | fhir |
hl7.fhir.us.pq-cmc-fda | R5 | cmc-specification-types-vs | Specification Section Type Terminology | draft | 2024-10 | us | fhir |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-analytical-instrument-data-types | Analytical Instrument Data File Types | draft | 2024-10 | us | ietf |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-chemical-structure-datafile-type-terminology | Chemical Structure Data File Type Terminology | draft | 2024-10 | us | fhir |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-closure-type-terminology | Closure Type Terminology | draft | 2024-10 | us | fhir |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-coating-purpose | Coating Purpose Terminology | draft | 2024-10 | us | fhir |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-container-type-terminology | Container Type Terminology | draft | 2024-10 | us | fhir |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-drug-product-component-function-category-terminology | Drug Product Component Function Category Terminology | draft | 2024-10 | us | fhir |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-excipient-function-terminology | Excipient Function Terminology | draft | 2024-10 | us | fhir |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-genc-and-iso-intersect | GENC and ISO 3166 Intersection | draft | 2024-10 | us | fhir |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-graphical-file-types | Graphical File Types | draft | 2024-10 | us | ietf |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-manufactured-dose-form-terminology | Manufactured Dose Form Terminology | draft | 2024-10 | us | fhir |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-name-part-terminology | PQCMC Name Part Terminology | draft | 2024-10 | us | tho |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-non-percentage-units | Non-Percentage Units | draft | 2024-10 | us | fhir |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-org-identifier-type-terminology | Organization-Site Identifier Terminology | draft | 2024-10 | us | fhir |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-percentage-units | Percentage Units | draft | 2024-10 | us | ucum |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-product-characteristic | PQCMC Product Characteristic | draft | 2024-10 | us | fhir |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-product-part-ingredient-physical-location | Ingredient Location Terminology | draft | 2024-10 | us | fhir |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-product-part-type | Product Part Type Terminology | draft | 2024-10 | us | fhir |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-quality-benchmark-terminology | Quality Benchmark Terminology | draft | 2024-10 | us | fhir |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-release-mechanism | Release Mechanism Terminology | draft | 2024-10 | us | fhir |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-release-profile | Release Profile Terminology | draft | 2024-10 | us | fhir |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-representation-types | Representation Types | draft | 2024-10 | us | fhir |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-source-type-terminology | Source Type Terminology | draft | 2024-10 | us | fhir |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-specification-status-terminology | Specification Status Terminology | draft | 2024-10 | us | fhir |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-specification-type-terminology | Specification Type Terminology | draft | 2024-10 | us | fhir |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-strength-type-terminology | Strength Type Terminology | draft | 2024-10 | us | fhir |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-structure-data-types | Structure Data Types | draft | 2024-10 | us | ietf |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-substance-name-type | Substance Name Type | draft | 2024-10 | us | fhir |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-test-category-terminology | Test Category Terminology | draft | 2024-10 | us | fhir |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-test-method-origin-terminology | Test Method Origin Terminology | draft | 2024-10 | us | fhir |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-test-usage-terminology | Test Usage Terminology | draft | 2024-10 | us | fhir |
hl7.fhir.us.pq-cmc-fda | R5 | pqcmc-units-of-measure | Units Of Measure | draft | 2024-10 | us | ucum |
hl7.fhir.us.pq-cmc-fda | R5 | spl-drug-route-of-administration-terminology | Drug Route Of Administration Terminology | draft | 2024-10 | us | fhir |
hl7.fhir.us.pq-cmc-fda | R5 | spl-pharmaceutical-dosage-form-terminology | Pharmaceutical Dosage Form Terminology | draft | 2024-10 | us | fhir |
hl7.fhir.us.pq-cmc-fda | R5 | substance-classification | Substance Classification | draft | 2024-10 | us | fhir |
hl7.fhir.pt.obs-neonat | R4 | bulletin-delivery-vs | bulletindeliveryVS ValueSet | active | 2024-10 | pt | |
hl7.fhir.pt.obs-neonat | R4 | document-type-vs | documenttypeVS ValueSet | active | 2024-10 | pt | sct |
hl7.fhir.pt.obs-neonat | R4 | episode-type-vs | Tipos de episódio ValueSet | active | 2024-10 | pt | |
hl7.fhir.pt.obs-neonat | R4 | newbornriskassessment-vs | newbornriskassessment ValueSet | active | 2024-10 | pt | sct |
hl7.fhir.pt.obs-neonat | R4 | puerperium-vs | puerpério ValueSet | active | 2024-10 | pt | sct |
hl7.fhir.pt.obs-neonat | R4 | risco-gravidez-vs | Risco de gravidez ValueSet | active | 2024-10 | pt | sct |
hl7.fhir.pt.obs-neonat | R4 | tipo-gravidez-vs | Tipo de gravidez ValueSet | active | 2024-10 | pt | sct |
hl7.fhir.pt.obs-neonat | R4 | tipo-parto-vs | Tipos de parto ValueSet | active | 2024-10 | pt | sct |
hl7.fhir.pt.obs-neonat | R4 | transport-type-vs | Tipos de transporte de recem-nascido ValueSet | active | 2024-10 | pt | sct |
hl7.fhir.pt.obs-neonat | R4 | vacinas-infancia-vs | Vacinas ValueSet | active | 2024-10 | pt | sct |
hl7.fhir.us.davinci-atr | R4 | atr-attribution-list-status | DaVinci Attribution List Status | active | 2020-09 | us | fhir |
hl7.fhir.us.davinci-atr | R4 | atr-changetype | DaVinci ATR Change Types | active | 2020-09 | us | fhir |
hl7.fhir.us.davinci-atr | R4 | davinci-group-characteristic | DaVinci Group Characteristic | active | 2020-09 | us | fhir |
fhir.cqf.common | R4 | active-condition | CQF Active Condition | active | 2019-07 | us | tho |
fhir.cqf.common | R4 | inactive-condition | CQF Inactive Condition | active | 2019-07 | us | tho |
hl7.fhir.uv.fhir-for-fair | R4B | related-artifact-type | RelatedArtifactType [ValueSet] | active | 2024-01 | uv | fhir |
hl7.fhir.us.core | R4 | detailed-ethnicity | Detailed ethnicity | active | 2022-09 | us | vsac |
hl7.fhir.us.core | R4 | detailed-race | Detailed Race | active | 2022-09 | us | vsac |
hl7.fhir.us.core | R4 | omb-ethnicity-category | OMB Ethnicity Categories | active | 2022-09 | us | vsac |
hl7.fhir.us.core | R4 | omb-race-category | OMB Race Categories | active | 2022-09 | us | vsac |
hl7.fhir.us.core | R4 | simple-language | Language codes with language and optionally a region modifier | active | 2022-09 | us | ietf |
hl7.fhir.us.core | R4 | us-core-clinical-note-type | US Core Clinical Note Type | active | 2024-05 | us | loinc |
hl7.fhir.us.core | R4 | us-core-clinical-result-observation-category | US Core Clinical Result Observation Category | active | 2023-04 | us | tho |
hl7.fhir.us.core | R4 | us-core-condition-code | US Core Condition Codes | active | 2022-09 | us | sct tho icd |
hl7.fhir.us.core | R4 | us-core-diagnosticreport-category | US Core Diagnostic Report Category Codes | active | 2022-09 | us | loinc |
hl7.fhir.us.core | R4 | us-core-diagnosticreport-report-and-note-codes | US Core Non Laboratory Codes | active | 2022-09 | us | loinc |
hl7.fhir.us.core | R4 | us-core-discharge-disposition | US Core Discharge Disposition | active | 2024-04 | us | |
hl7.fhir.us.core | R4 | us-core-documentreference-category | US Core DocumentReference Category | active | 2022-09 | us | fhir |
hl7.fhir.us.core | R4 | us-core-documentreference-type | US Core DocumentReference Type | active | 2022-09 | us | tho loinc |
hl7.fhir.us.core | R4 | us-core-encounter-type | US Core Encounter Type | active | 2022-09 | us | sct cpt |
hl7.fhir.us.core | R4 | us-core-goal-description | US Core Goal Codes | active | 2022-09 | us | sct loinc |
hl7.fhir.us.core | R4 | us-core-laboratory-test-codes | US Core Laboratory Test Codes | active | 2022-11 | us | loinc |
hl7.fhir.us.core | R4 | us-core-location-type | US Core Location Type | active | 2024-10 | us | vsac tho |
hl7.fhir.us.core | R4 | us-core-narrative-status | US Core Narrative Status | active | 2022-09 | us | fhir |
hl7.fhir.us.core | R4 | us-core-observation-smoking-status-status | US Core Status for Smoking Status Observation | active | 2022-09 | us | fhir |
hl7.fhir.us.core | R4 | us-core-pregnancy-intent | US Core Pregnancy Intent Codes | active | 2022-09 | us | vsac tho |
hl7.fhir.us.core | R4 | us-core-pregnancy-status | US Core Pregnancy Status Codes | active | 2022-09 | us | vsac tho |
hl7.fhir.us.core | R4 | us-core-problem-or-health-concern | US Core Problem or Health Concern | active | 2022-09 | us | fhir tho |
hl7.fhir.us.core | R4 | us-core-procedure-code | US Core Procedure Codes | active | 2022-09 | us | sct cpt cms loinc |
hl7.fhir.us.core | R4 | us-core-provenance-participant-type | US Core Provenance Participant Type Codes | active | 2022-09 | us | fhir tho |
hl7.fhir.us.core | R4 | us-core-screening-assessment-condition-category | US Core Screening Assessment Condition Category | active | 2023-04 | us | fhir |
hl7.fhir.us.core | R4 | us-core-screening-assessment-observation-category | US Core Screening Assessment Observation Category | active | 2023-03 | us | fhir |
hl7.fhir.us.core | R4 | us-core-servicerequest-category | US Core ServiceRequest Category Codes | active | 2022-09 | us | fhir sct |
hl7.fhir.us.core | R4 | us-core-simple-observation-category | US Core Simple Observation Category | active | 2022-09 | us | fhir tho |
hl7.fhir.us.core | R4 | us-core-survey-codes | US Core Survey Codes | active | 2022-09 | us | loinc |
hl7.fhir.us.core | R4 | us-core-usps-state | USPS Two Letter Alphabetic Codes | active | 2022-09 | us | |
hl7.fhir.us.mihr | R4 | PregnancyNonLive | Pregnancy Non-Live | draft | 2023-03 | us | vsac |
hl7.fhir.us.mihr | R4 | PregnancyProcedureDelivery-CPT | Pregnancy Procedure Delivery CPT | draft | 2023-03 | us | cpt |
hl7.fhir.us.mihr | R4 | PregnancyProcedureDelivery | Pregnancy Procedure Delivery | draft | 2023-03 | us | fhir vsac |
hl7.fhir.us.mihr | R4 | hypertensive-disorders-pregnancy-ICD | ValueSet – Hypertensive Disorders of Pregnancy ICD | draft | 2023-03 | us | icd |
hl7.fhir.us.mihr | R4 | hypertensive-disorders-pregnancy-SNOMED | ValueSet – Hypertensive Disorders of Pregnancy SNOMED CT | draft | 2023-03 | us | sct |
hl7.fhir.us.mihr | R4 | hypertensive-disorders-pregnancy | ValueSet – Hypertensive Disorders of Pregnancy | draft | 2023-03 | us | fhir |
hl7.fhir.us.mihr | R4 | pregnancy | Pregnancy | draft | 2023-03 | us | vsac |
hl7.fhir.uv.fhir-clinical-document | R4 | clinical-doc-information-recipient-vs | Clinical Document Participant Types that are information recipients | draft | 2024-08 | uv | tho |
hl7.fhir.uv.fhir-clinical-document | R4 | clinical-doc-participant-types-vs | Clinical Document Participant Types Value set | draft | 2024-08 | uv | tho |
hl7.fhir.uv.fhir-clinical-document | R4 | clinical-doc-participant-vs | Clinical Document Participant Value set | draft | 2024-08 | uv | tho |
hl7.fhir.uv.dap | R5 | MyOrgRolesVS | Current Roles in MyOrg | draft | 2024-08 | uv | fhir |
hl7.fhir.us.covid19library | R4 | Ab-det-past-recent-infection-vs | Antibody Not Detected, Past/Recent Infection LOINC answer value set. | active | 2022-07 | us | loinc |
hl7.fhir.us.covid19library | R4 | close-contact-setting-vs | Close Contact Setting Value Set | active | 2022-07 | us | sct |
hl7.fhir.us.covid19library | R4 | covid-19-disease-severity-value-set | COVID-19 Disease Severity Value Set | active | 2022-07 | us | sct |
hl7.fhir.us.covid19library | R4 | covid-19-icd-diagnosis-vs | COVID-19 ICD 10 Diagnosis Value Set | active | 2022-07 | us | icd |
hl7.fhir.us.covid19library | R4 | covid-19-severity-value-set | COVID-19 Signs and Symptoms Severity Value Set | active | 2022-07 | us | sct |
hl7.fhir.us.covid19library | R4 | covid-19-snomed-diagnosis-vs | COVID-19 SNOMED CT Diagnosis Value Set | active | 2022-07 | us | sct |
hl7.fhir.us.covid19library | R4 | covid19-cvx-codes-value-set | COVID 19 CVX Code System Vaccine Codes | active | 2022-07 | us | cvx |
hl7.fhir.us.covid19library | R4 | covid19-det-notdet-eq-inc-vs | Detected, Not Detected, Inconclusive Value Set | active | 2022-07 | us | sct |
hl7.fhir.us.covid19library | R4 | covid19-det-notdet-vs | Detected, Not-detected value set | active | 2022-07 | us | sct |
hl7.fhir.us.covid19library | R4 | covid19-detected-genetic-mutation-la-codes-value-set | Detected Genetic Mutations LOINC answer codes value set | active | 2022-07 | us | loinc |
hl7.fhir.us.covid19library | R4 | covid19-pos-neg-eqvs | Positive/Negative Value Set | active | 2022-07 | us | fhir sct |
hl7.fhir.us.covid19library | R4 | covid19-pos-neg-ind-vs | COVID19 Positive, Negative, Indeterminate value set | active | 2022-07 | us | sct |
hl7.fhir.us.covid19library | R4 | covid19-pos-neg-inv-incl-vs | COVID19 Positive, Negative, Invalid, Inconclusive value set | active | 2022-07 | us | fhir sct |
hl7.fhir.us.covid19library | R4 | covid19-pos-neg-inv-vs | COVID19 Positive Negative Invalid value set | active | 2022-07 | us | fhir sct |
hl7.fhir.us.covid19library | R4 | covid19-pos-neg-susp-inv-vs | COVID19 Positive Negative Suspected Invalid value set | active | 2022-07 | us | fhir sct |
hl7.fhir.us.covid19library | R4 | covid19-pos-neg-vs | Positive, Negative value set | active | 2022-07 | us | sct |
hl7.fhir.us.covid19library | R4 | covid19-react-nonreact-borderline-inv-value-set | Reactive, Non-reactive, Borderline, Invalid value set | active | 2022-07 | us | fhir sct |
hl7.fhir.us.covid19library | R4 | covid19-react-nonreact-inv-vs | COVID19 Reactive, Non-reactive, Invalid value set | active | 2022-07 | us | fhir sct |
hl7.fhir.us.covid19library | R4 | covid19-react-nonreact-vs | COVID19 Reactive Non-reactive value set | active | 2022-07 | us | sct |
hl7.fhir.us.covid19library | R4 | covid19-reporting-priority-vs | Reporting Priorities Value Set | active | 2022-07 | us | sct |
hl7.fhir.us.covid19library | R4 | covid19-signs-1nd-symptoms-value-set | COVID-19 Signs and Symptoms Value Set | active | 2022-07 | us | sct |
hl7.fhir.us.covid19library | R4 | covid19-underlying-cardiovascular-condition-value-set | COVID-19 cardiovascular underlying condition reference set | active | 2022-07 | us | sct |
hl7.fhir.us.covid19library | R4 | covid19-underlying-gastrointestinal-hepatic-condition-value-set | COVID-19 gastrointestinal or hepatic underlying condition reference set | active | 2022-07 | us | sct |
hl7.fhir.us.covid19library | R4 | covid19-underlying-immune-condition-value-set | COVID-19 immune underlying condition reference set | active | 2022-07 | us | sct |
hl7.fhir.us.covid19library | R4 | covid19-underlying-immunocompromised-condition-value-set | COVID-19 immunocompromised underlying condition reference set | active | 2022-07 | us | sct |
hl7.fhir.us.covid19library | R4 | covid19-underlying-medical-condition-vs | COVID-19 Underlying Medical Condition Value Set | active | 2022-07 | us | sct |
hl7.fhir.us.covid19library | R4 | covid19-underlying-metabolic-condition-value-set | COVID-19 metabolic underlying condition reference set | active | 2022-07 | us | sct |
hl7.fhir.us.covid19library | R4 | covid19-underlying-neurolgic-condition-value-set | COVID-19 neurologic underlying condition reference set | active | 2022-07 | us | sct |
hl7.fhir.us.covid19library | R4 | covid19-underlying-renal-condition-value-set | COVID-19 renal underlying condition reference set | active | 2022-07 | us | sct |
hl7.fhir.us.covid19library | R4 | covid19-underlying-respiratory-condition-value-set | COVID-19 respiratory underlying condition reference set | active | 2022-07 | us | sct |
hl7.fhir.us.covid19library | R4 | covid19-underlying-uncategorized-condition-value-set | COVID-19 uncategorized underlying condition reference set | active | 2022-07 | us | sct |
hl7.fhir.us.covid19library | R4 | covid19-who-path-la-codes-value-set | World Health Organization, COVID-19 variant LOINC answer code value set | active | 2022-07 | us | loinc |
hl7.fhir.us.covid19library | R4 | covid91-underlying-hemoglobinopathy-condition-value-set | COVID-19 hemoglobinopathy underlying condition reference set | active | 2022-07 | us | sct |
hl7.fhir.us.covid19library | R4 | det-notdet-equivocal-invalid-vs | Detected, Not-detected, Equivocal, Invalid value set | active | 2022-07 | us | fhir sct |
hl7.fhir.us.covid19library | R4 | det-notdet-inconclusive-invalid-vs | Detected, Not-detected, Inconclusive, Invalid value set | active | 2022-07 | us | fhir sct |
hl7.fhir.us.covid19library | R4 | detected-not-detected-value-set | Detected, Not-detected Value Set | active | 2022-07 | us | sct |
hl7.fhir.us.covid19library | R4 | exposure-type-la-value-set | Exposure Type LOINC Answer Value Set | active | 2022-07 | us | loinc |
hl7.fhir.us.covid19library | R4 | fluAB-SARSCoV2-SARSCoV-value-set | Influenza A, Influenza B, SARS CoV 2, and SARS CoV value set | active | 2022-07 | us | sct |
hl7.fhir.us.covid19library | R4 | fluAB-SARSCoV2-value-set | Influenza A, Influenza B, and SARS CoV2 value set | active | 2022-07 | us | sct |
hl7.fhir.us.covid19library | R4 | iso-country-codes-value-set | ISO Code System 3166 country codes | active | 2022-07 | us | iso |
hl7.fhir.us.covid19library | R4 | iso-state-codes-value-set | ISO Code System 3166 state/province codes. | active | 2022-07 | us | iso |
hl7.fhir.us.covid19library | R4 | pregnancy-status-value-set | Pregnancy Status Value Set | active | 2022-07 | us | sct |
hl7.fhir.us.covid19library | R4 | present-absent-unknown-vs | Present, Absent, Unknown Value Set | active | 2022-07 | us | sct |
hl7.fhir.us.covid19library | R4 | reactive-non-reactive-value-set | Reactive - Non-reactive value set | active | 2022-07 | us | sct |
hl7.fhir.us.covid19library | R4 | sars-cov2-clade-loinc-answer-value-set | SARS CoV 2 Clade Assignment LOINC Answer value set | active | 2022-07 | us | loinc |
hl7.fhir.us.covid19library | R4 | sars-cov2-lineage-loinc-answer-value-set | SARS CoV 2 Lineage LOINC Answers | active | 2022-07 | us | loinc |
hl7.fhir.us.covid19library | R4 | sars-cov2-rdrp-mutation-vs | SARS CoV 2 RdRp Gene Mutation value set | active | 2022-07 | us | loinc |
hl7.fhir.us.covid19library | R4 | smoking-status-value-set | Smoking Status Value Set | active | 2022-07 | us | sct |
hl7.fhir.us.covid19library | R4 | state-codes-vs | State Codes Value Set | active | 2022-07 | us | sct |
hl7.fhir.us.covid19library | R4 | yes-no-vs | Yes/No Value Set | active | 2022-07 | us | sct |
hl7.fhir.uv.rtls | R4 | http://terminology.hl7.org/fhir/uv/rtls/ValueSet/rtlsMessageEvents | RTLS Message Events Valueset | draft | 2022-10 | uv | fhir |
hl7.eu.fhir.xpandh | R4 | eHDSIAbsentOrUnknownAllergy | Absent or Unknown Allergies | active | 2024-10 | eu | fhir |
hl7.eu.fhir.xpandh | R4 | eHDSIAbsentOrUnknownDevice | Absent or Unknown Device | active | 2024-10 | eu | fhir |
hl7.eu.fhir.xpandh | R4 | eHDSIAbsentOrUnknownMedication | Absent or Unknown Medication | active | 2024-10 | eu | fhir |
hl7.eu.fhir.xpandh | R4 | eHDSIAbsentOrUnknownProblem | Absent or Unknown Problem | active | 2024-10 | eu | fhir |
hl7.eu.fhir.xpandh | R4 | eHDSIAbsentOrUnknownProcedure | Absent or Unknown Procedure | active | 2024-10 | eu | fhir |
hl7.eu.fhir.xpandh | R4 | eHDSIAdverseEventType | Adverse Event Type | active | 2024-10 | eu | sct |
hl7.eu.fhir.xpandh | R4 | eHDSIAllergenNoDrug | Allergen No Drug | active | 2024-10 | eu | sct |
hl7.eu.fhir.xpandh | R4 | eHDSIAllergyCertainty | Allergy Certainty | active | 2024-10 | eu | tho |
hl7.eu.fhir.xpandh | R4 | eHDSIAllergyStatus | Allergy Status | active | 2024-10 | eu | tho |
hl7.eu.fhir.xpandh | R4 | eHDSIBloodGroup | Blood Group | active | 2024-10 | eu | sct |
hl7.eu.fhir.xpandh | R4 | eHDSIBloodPressure | Blood Pressure | active | 2024-10 | eu | loinc |
hl7.eu.fhir.xpandh | R4 | eHDSICertainty | Certainty | active | 2024-10 | eu | tho |
hl7.eu.fhir.xpandh | R4 | eHDSICodeProb | Problems | active | 2024-10 | eu | sct |
hl7.eu.fhir.xpandh | R4 | eHDSIConfidentiality | Confidentiality | active | 2024-10 | eu | tho |
hl7.eu.fhir.xpandh | R4 | eHDSICountry | Country | active | 2024-10 | eu | iso |
hl7.eu.fhir.xpandh | R4 | eHDSICriticality | Criticality | active | 2024-10 | eu | fhir |
hl7.eu.fhir.xpandh | R4 | eHDSICurrentPregnancyStatus | Current Pregnancy Status | active | 2024-10 | eu | sct |
hl7.eu.fhir.xpandh | R4 | eHDSIDocumentCode | Document Code | active | 2024-10 | eu | loinc |
hl7.eu.fhir.xpandh | R4 | eHDSIDoseForm | Dose Form | active | 2024-10 | eu | |
hl7.eu.fhir.xpandh | R4 | eHDSIHealthcareProfessionalRole | Healthcare Professional Role | active | 2024-10 | eu | oid |
hl7.eu.fhir.xpandh | R4 | eHDSIHospitalDischargeReportType | Hospital Discharge Report Type | active | 2024-10 | eu | loinc |
hl7.eu.fhir.xpandh | R4 | eHDSIProcedure | Procedure | active | 2024-10 | eu | sct |
hl7.eu.fhir.xpandh | R4 | eHDSIReactionAllergy | Reaction Allergy | active | 2024-10 | eu | sct |
hl7.eu.fhir.xpandh | R4 | eHDSISeverity | Severity | active | 2024-10 | eu | sct |
hl7.eu.fhir.xpandh | R4 | eHDSISocialHistory | eHDSI Social History | active | 2024-10 | eu | sct |
hl7.eu.fhir.xpandh | R4 | eHDSIVaccine | Vaccine | active | 2024-10 | eu | atc sct |
ch.fhir.ig.ch-alis | R4 | ch-alis-paramtyp | CH ALIS ParamTyp | draft | 2020-11 | ch | internal |
ch.fhir.ig.ch-alis | R4 | ch-alis-persontyp | CH ALIS PersonTyp | draft | 2020-11 | ch | internal |
hl7.fhir.uv.ebm | R6 | evidence-report-contributor-role | Evidence Report Contributor Role Value Set | draft | 2024-10 | uv | fhir |
hl7.fhir.uv.ebm | R6 | evidence-variable-role-subtype | Evidence Variable Role Subtype Value Set | draft | 2024-10 | uv | tho |
hl7.fhir.uv.ebm | R6 | recommendation-justification-classifier | Recommendation Justification Classifier Codes Value Set | draft | 2024-10 | uv | |
hl7.fhir.cl.agenda | R4 | VSCategorias | VS Prestaciones | active | 2024-10 | cl | internal |
hl7.fhir.cl.agenda | R4 | VSPrestaciones | VS Prestaciones | active | 2024-10 | cl | internal |
hl7.fhir.cl.agenda | R4 | VSPrevision | VS Prevision | active | 2024-10 | cl | internal |
hl7.fhir.cl.agenda | R4 | VSServicios | VS SERVICIOS | active | 2024-10 | cl | internal |
hl7.fhir.uv.epi-test | R5 | PDcategoryVS | PDcategoryVS | active | 2024-04 | uv | |
hl7.fhir.uv.epi-test | R5 | PDtypeVS | PDtypeVS | active | 2024-04 | uv | |
hl7.fhir.uv.epi-test | R5 | dl-category-vs | DLCategoryVS | active | 2024-04 | uv | fhir |
fhir.nachc.hiv-cds | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1056.52 | Indicators of Human Immunodeficiency Virus (HIV) | active | 2024-08 | us | |
fhir.nachc.hiv-cds | R4 | GayOrBisexual | Gay Or Bisexual | active | 2024-08 | us | internal sct |
fhir.nachc.hiv-cds | R4 | Transgender | Transgender | active | 2024-08 | us | internal sct |
fhir.nachc.hiv-cds | R4 | nachc-a0-de2 | Encounter Type Codes | draft | 2024-08 | us | cpt |
fhir.nachc.hiv-cds | R4 | nachc-a0-de49 | Sexual Orientation Codes | draft | 2024-08 | us | sct |
fhir.nachc.hiv-cds | R4 | nachc-a0-de56 | Gender Identity Codes | draft | 2024-08 | us | sct |
fhir.nachc.hiv-cds | R4 | nachc-a1-de2 | HIV infection as a condition Codes | draft | 2024-08 | us | sct icd |
fhir.nachc.hiv-cds | R4 | nachc-a2-de1-codes-grouper | HIV Test Codes Grouper | draft | 2022-01 | us | internal |
fhir.nachc.hiv-cds | R4 | nachc-a2-de173 | HIV Viral Load Codes | draft | 2024-08 | us | loinc |
fhir.nachc.hiv-cds | R4 | nachc-a2-de2 | HIV-1 HIV 2 Ab Ag tests Codes | draft | 2024-08 | us | loinc |
fhir.nachc.hiv-cds | R4 | nachc-a2-de217 | HIV Test Ordered Codes | draft | 2024-08 | us | sct |
fhir.nachc.hiv-cds | R4 | nachc-b1-de1-codes-grouper | Hepatitis C Diagnosis Codes Grouper | draft | 2022-01 | us | internal |
fhir.nachc.hiv-cds | R4 | nachc-b1-de2 | Hepatitis C Virus Infection (Disorders) Codes | draft | 2024-08 | us | sct icd |
fhir.nachc.hiv-cds | R4 | nachc-b1-de31 | Chronic Infection of liver due to Hepatitis C virus Codes | draft | 2024-08 | us | sct |
fhir.nachc.hiv-cds | R4 | nachc-b1-de33 | HCV Infection (Organism or Substance in Lab Results) Codes | draft | 2024-08 | us | sct |
fhir.nachc.hiv-cds | R4 | nachc-b1-de61 | Hepatitis C condition Codes | draft | 2024-08 | us | sct |
fhir.nachc.hiv-cds | R4 | nachc-b2-de1-codes-grouper | Hepatitis C Test Codes Grouper | draft | 2022-01 | us | internal |
fhir.nachc.hiv-cds | R4 | nachc-b2-de103 | Hepatitis C Test Codes | draft | 2024-08 | us | internal cpt cms |
fhir.nachc.hiv-cds | R4 | nachc-b2-de113 | Hepatitis C Procedures Codes | draft | 2024-08 | us | internal |
fhir.nachc.hiv-cds | R4 | nachc-b2-de2 | Hepatitis C Ag Codes | draft | 2024-08 | us | loinc |
fhir.nachc.hiv-cds | R4 | nachc-b2-de41 | Hepatitis C virus antibody test Codes | draft | 2024-08 | us | loinc |
fhir.nachc.hiv-cds | R4 | nachc-b2-de5 | Hepatitis C nucleic acid Codes | draft | 2024-08 | us | loinc |
fhir.nachc.hiv-cds | R4 | nachc-b2-de81 | Hepatitis C virus nucleic (RNA) test Codes | draft | 2024-08 | us | loinc |
fhir.nachc.hiv-cds | R4 | nachc-c1-de1-codes-grouper | Syphilis Diagnosis Codes Grouper | draft | 2022-01 | us | internal |
fhir.nachc.hiv-cds | R4 | nachc-c1-de185 | Syphilis (Organism or Substance in Lab Results) Codes | draft | 2024-08 | us | sct |
fhir.nachc.hiv-cds | R4 | nachc-c1-de192 | Syphilis condition Codes | draft | 2024-08 | us | sct icd |
fhir.nachc.hiv-cds | R4 | nachc-c1-de2 | Syphilis Codes | draft | 2024-08 | us | sct |
fhir.nachc.hiv-cds | R4 | nachc-c2-de1-codes-grouper | Syphilis Test Codes Grouper | draft | 2022-01 | us | internal |
fhir.nachc.hiv-cds | R4 | nachc-c2-de2 | Syphilis (Tests for Treponema pallidum Nucleic Acid) Codes | draft | 2024-08 | us | loinc |
fhir.nachc.hiv-cds | R4 | nachc-c2-de8 | Syphilis (Tests for Treponemal or Non Antibody) Codes | draft | 2024-08 | us | loinc |
fhir.nachc.hiv-cds | R4 | nachc-d1-de1-codes-grouper | Gonorrhea Diagnosis Codes Grouper | draft | 2022-01 | us | internal |
fhir.nachc.hiv-cds | R4 | nachc-d1-de167 | Gonorrhea Organism or Substance in Lab Results Codes | draft | 2024-08 | us | sct |
fhir.nachc.hiv-cds | R4 | nachc-d1-de182 | Gonorrhea Secondary Sites Codes | draft | 2024-08 | us | sct |
fhir.nachc.hiv-cds | R4 | nachc-d1-de2 | Gonococcal Infections and Venereal Diseases Codes | draft | 2024-08 | us | sct icd |
fhir.nachc.hiv-cds | R4 | nachc-d2-de1-codes-grouper | Gonorrhea Test Codes Grouper | draft | 2022-01 | us | internal |
fhir.nachc.hiv-cds | R4 | nachc-d2-de101 | Gonorrhea Tests and Chlamydia/Gonorrhea Combined Tests Codes | draft | 2024-08 | us | loinc |
fhir.nachc.hiv-cds | R4 | nachc-d2-de17 | Gonorrhea Tests for Neisseria Nucleic Acid Codes | draft | 2024-08 | us | loinc |
fhir.nachc.hiv-cds | R4 | nachc-d2-de2 | Gonorrhea Tests for Neisseria gonorrhea by Culture Codes | draft | 2024-08 | us | loinc |
fhir.nachc.hiv-cds | R4 | nachc-d2-de60 | Gonorrhea Tests for Neisseria species by Culture Codes | draft | 2024-08 | us | loinc |
fhir.nachc.hiv-cds | R4 | nachc-d2-de67 | Gonorrhea test Codes | draft | 2024-08 | us | loinc |
fhir.nachc.hiv-cds | R4 | nachc-e1-de1-codes-grouper | Chlamydia Diagnosis Codes Grouper | draft | 2022-01 | us | internal |
fhir.nachc.hiv-cds | R4 | nachc-e1-de2 | Chlamydia Codes | draft | 2024-08 | us | sct icd |
fhir.nachc.hiv-cds | R4 | nachc-e1-de27 | Chlamydia Infections and Venereal Diseases Codes | draft | 2024-08 | us | sct |
fhir.nachc.hiv-cds | R4 | nachc-e1-de32 | Chlamydia trachomatis Infection Codes | draft | 2024-08 | us | sct |
fhir.nachc.hiv-cds | R4 | nachc-e1-de63 | Chlamydia trachomatis organism Codes | draft | 2024-08 | us | sct |
fhir.nachc.hiv-cds | R4 | nachc-e2-de1-codes-grouper | Chlamydia Test Codes Grouper | draft | 2022-01 | us | internal |
fhir.nachc.hiv-cds | R4 | nachc-e2-de123 | Chlamydia Trachomatis Tests, FPAR Codes | draft | 2024-08 | us | loinc |
fhir.nachc.hiv-cds | R4 | nachc-e2-de125 | Tests for Chlamydia trachomatis Antigen Codes | draft | 2024-08 | us | loinc |
fhir.nachc.hiv-cds | R4 | nachc-e2-de154 | Tests for Chlamydia trachomatis by Culture Codes | draft | 2024-08 | us | loinc |
fhir.nachc.hiv-cds | R4 | nachc-e2-de164 | Tests for Chlamydia trachomatis Nucleic Acid Codes | draft | 2024-08 | us | loinc |
fhir.nachc.hiv-cds | R4 | nachc-e2-de2 | Chlamydia Screening Codes | draft | 2024-08 | us | loinc |
fhir.nachc.hiv-cds | R4 | nachc-e2-de49 | Chlamydia test Codes | draft | 2024-08 | us | loinc |
fhir.nachc.hiv-cds | R4 | nachc-f1-de13 | Injection Findings Codes | draft | 2024-08 | us | sct |
fhir.nachc.hiv-cds | R4 | nachc-f1-de16 | Injection Drug Use Diagnosis Codes | draft | 2024-08 | us | sct icd |
fhir.nachc.hiv-cds | R4 | nachc-f1-de2 | Drug Rehabilitation Codes | draft | 2024-08 | us | sct |
fhir.nachc.hiv-cds | R4 | nachc-f1-de201 | Injection Drug Use Codes | draft | 2024-08 | us | icd |
fhir.nachc.hiv-cds | R4 | nachc-f2-de109 | Maternal Care Codes | draft | 2024-08 | us | icd |
fhir.nachc.hiv-cds | R4 | nachc-f2-de1132 | Pregnancy Conditions Codes | draft | 2024-08 | us | sct icd |
fhir.nachc.hiv-cds | R4 | nachc-f2-de2 | Pregnancy Encounters Codes | draft | 2024-08 | us | icd |
fhir.nachc.hiv-cds | R4 | nachc-f2-de39 | Third Trimester Encounters Codes | draft | 2024-08 | us | icd |
fhir.nachc.hiv-cds | R4 | nachc-f2-de43 | Pregnancy Supervision Codes | draft | 2024-08 | us | icd |
fhir.nachc.hiv-cds | R4 | nachc-f2-de673 | Pregnancy Procedures Codes | draft | 2024-08 | us | sct cpt |
fhir.nachc.hiv-cds | R4 | nachc-f2-de905 | Pregnancy Observations Codes | draft | 2024-08 | us | sct loinc |
fhir.nachc.hiv-cds | R4 | nachc-g1-de100 | Alternative nPEP Order Codes | draft | 2024-08 | us | rx |
fhir.nachc.hiv-cds | R4 | nachc-g1-de143-codes-grouper | PEP Dispensed Medications Codes Grouper | draft | 2022-01 | us | internal |
fhir.nachc.hiv-cds | R4 | nachc-g1-de144 | Preferred nPEP Supplied Codes | draft | 2024-08 | us | ndc |
fhir.nachc.hiv-cds | R4 | nachc-g1-de2 | Post Exposure Prophylaxis Codes | draft | 2024-08 | us | sct |
fhir.nachc.hiv-cds | R4 | nachc-g1-de299 | Alternative nPEP Supplied Codes | draft | 2024-08 | us | ndc |
fhir.nachc.hiv-cds | R4 | nachc-g1-de5-codes-grouper | PEP Medication Prescriptions Codes Grouper | draft | 2022-01 | us | internal |
fhir.nachc.hiv-cds | R4 | nachc-g1-de6 | Preferred nPEP Order Codes | draft | 2024-08 | us | rx |
fhir.nachc.hiv-cds | R4 | nachc-g2-de1-codes-grouper | Prep Medication Prescriptions Codes Grouper | draft | 2022-01 | us | internal |
fhir.nachc.hiv-cds | R4 | nachc-g2-de15 | TDF 300mg / FTC 200mg Order Codes | draft | 2024-08 | us | rx |
fhir.nachc.hiv-cds | R4 | nachc-g2-de18 | Tenofovir Alafenamide (TAF) 25 mg Order Codes | draft | 2024-08 | us | rx |
fhir.nachc.hiv-cds | R4 | nachc-g2-de2 | Emtricitabine (FTC) 200mg Order Codes | draft | 2024-08 | us | rx |
fhir.nachc.hiv-cds | R4 | nachc-g2-de22 | Tenofovir Disoproxil Fumarate (TDF) 300mg Order Codes | draft | 2024-08 | us | rx |
fhir.nachc.hiv-cds | R4 | nachc-g2-de26-codes-grouper | Prep Dispensed Medications Codes Grouper | draft | 2022-01 | us | internal |
fhir.nachc.hiv-cds | R4 | nachc-g2-de27 | Emtricitabine (FTC) 200mg Supplied Codes | draft | 2024-08 | us | ndc |
fhir.nachc.hiv-cds | R4 | nachc-g2-de35 | TAF 25mg / FTC 200mg Supplied Codes | draft | 2024-08 | us | ndc |
fhir.nachc.hiv-cds | R4 | nachc-g2-de37 | TDF 300mg / FTC 200mg Supplied Codes | draft | 2024-08 | us | ndc |
fhir.nachc.hiv-cds | R4 | nachc-g2-de7 | TAF 25mg / FTC 200mg Order Codes | draft | 2024-08 | us | rx |
fhir.nachc.hiv-cds | R4 | nachc-g2-de78 | Tenofovir Alafenamide (TAF) 25 mg Supplied Codes | draft | 2024-08 | us | ndc |
fhir.nachc.hiv-cds | R4 | nachc-g2-de79 | Tenofovir Disoproxil Fumarate (TDF) 300mg Supplied Codes | draft | 2024-08 | us | ndc |
ch.fhir.ig.ch-atc | R4 | AccessAuditTrailEventType | AccessAuditTrailEventType | draft | 2018-05 | ch | oid |
ch.fhir.ig.ch-atc | R4 | DocumentAuditEventType | DocumentAuditEventType | draft | 2018-05 | ch | oid |
ch.fhir.ig.ch-atc | R4 | EprParticipant | EprParticipant | draft | 2018-05 | ch | oid |
ch.fhir.ig.ch-atc | R4 | HpdAuditEventType | HpdAuditEventType | draft | 2022-06 | ch | oid |
ch.fhir.ig.ch-atc | R4 | PolicyAuditEventType | PolicyAuditEventType | draft | 2018-05 | ch | oid |
ch.fhir.ig.ch-epr-mhealth | R4 | ChPdqmMoreAttriburesRequested | CH PDQm ValueSet More Attributes Requested | active | 2024-10 | ch | oid |
hl7.fhir.us.cimilabs | R4 | StdLabObsCoded-value-set | Standard Coded Lab Observation Code value set | draft | 2023-08 | us | loinc |
hl7.fhir.us.cimilabs | R4 | StdLabObsOrdinal-value-set | Standard Coded Ordinal Lab Observation Code value set | draft | 2023-08 | us | loinc |
hl7.fhir.us.cimilabs | R4 | abnml-int-numeric-nom-value-set | Abnormal Interpretation Numeric Nominal value set | draft | 2023-08 | us | sct |
hl7.fhir.us.cimilabs | R4 | abnormal-interpretation-value-set | Abnmormal Interpretation value set | draft | 2023-08 | us | sct |
hl7.fhir.us.cimilabs | R4 | lab-result-code-value-set | Lab Result Code value set | draft | 2023-08 | us | sct |
hl7.fhir.us.cimilabs | R4 | loinc-doc-value-set | LOINC Document class value set | draft | 2023-08 | us | loinc |
hl7.fhir.us.cimilabs | R4 | null-flavor-value-set | Null Flavor value set | draft | 2023-08 | us | sct |
hl7.fhir.us.cimilabs | R4 | ordinal-value-code-value-set | Ordinal Value Code value set | draft | 2023-08 | us | sct |
hl7.fhir.us.cimilabs | R4 | standard-lab-obs-narrative-value-set | Standard Lab Obs Narrative value set | draft | 2023-08 | us | loinc |
hl7.fhir.us.cimilabs | R4 | standard-lab-obs-quantitative-value-set | Standard Lab Obs Quantitative Code value set | draft | 2023-08 | us | loinc |
hl7.fhir.us.cimilabs | R4 | titer-lab-codes-value-set | Titer Lab Codes value set | draft | 2023-08 | us | loinc |
hl7.fhir.us.cimilabs | R4 | units-of-measure-value-set | Units of Measure value set | draft | 2023-08 | us | ucum |
hl7.fhir.uv.smart-app-launch | R4 | smart-launch-info | Codes for tasks to application launches | active | 2024-05 | uv | fhir |
hl7.fhir.uv.smart-app-launch | R4 | smart-launch-types | Launch Types for tasks to application launches | active | 2024-05 | uv | fhir |
hl7.fhir.uv.smart-app-launch | R4 | user-access-category | User Access Category Value Set | active | 2023-03 | uv | tho |
hl7.fhir.us.davinci-deqm | R4 | care-gap-reason | Care Gap Reasons Value Set | active | 2024-10 | us | fhir |
hl7.fhir.us.davinci-deqm | R4 | gaps-status | DEQM Gaps In Care Gap Status Value Set | active | 2021-04 | us | fhir |
hl7.fhir.us.davinci-deqm | R4 | update-type | DEQM Update Type Value Set | active | 2020-08 | us | fhir |
hl7.fhir.us.davinci-pdex-plan-net | R4 | AcceptingPatientsVS | Accepting Patients Codes VS | active | 2024-10 | us | fhir |
hl7.fhir.us.davinci-pdex-plan-net | R4 | AccessibilityVS | Accessibility VS | active | 2024-10 | us | fhir |
hl7.fhir.us.davinci-pdex-plan-net | R4 | DeliveryMethodVS | Delivery Methods VS | active | 2024-10 | us | fhir |
hl7.fhir.us.davinci-pdex-plan-net | R4 | EndpointConnectionTypeVS | Endpoint Connection Types VS | active | 2024-10 | us | fhir tho |
hl7.fhir.us.davinci-pdex-plan-net | R4 | EndpointPayloadTypeVS | Endpoint Payload Types VS | active | 2024-10 | us | fhir |
hl7.fhir.us.davinci-pdex-plan-net | R4 | EndpointUsecaseVS | Endpoint Usecases VS | active | 2024-10 | us | tho |
hl7.fhir.us.davinci-pdex-plan-net | R4 | HealthcareServiceCategoryVS | Healthcare Service CategoryVS | active | 2024-10 | us | fhir |
hl7.fhir.us.davinci-pdex-plan-net | R4 | HealthcareServiceTypeVS | HealthcareService Types VS | active | 2024-10 | us | tho |
hl7.fhir.us.davinci-pdex-plan-net | R4 | IndividualAndGroupSpecialtiesVS | Individual and Group Specialties | active | 2024-10 | us | nucc |
hl7.fhir.us.davinci-pdex-plan-net | R4 | IndividualSpecialtyAndDegreeLicenseCertificateVS | Individual Specialties, Degrees, Licenses, and Certificates VS | active | 2024-10 | us | fhir tho |
hl7.fhir.us.davinci-pdex-plan-net | R4 | InsurancePlanTypeVS | Insurance Plan TypeVS | active | 2024-10 | us | fhir |
hl7.fhir.us.davinci-pdex-plan-net | R4 | InsuranceProductTypeVS | Insurance Product Type VS | active | 2024-10 | us | fhir |
hl7.fhir.us.davinci-pdex-plan-net | R4 | LanguageProficiencyVS | Language Proficiency VS | active | 2024-10 | us | fhir |
hl7.fhir.us.davinci-pdex-plan-net | R4 | MinEndpointConnectionTypeVS | Minimum Endpoint Connection Types VS | active | 2024-10 | us | fhir tho |
hl7.fhir.us.davinci-pdex-plan-net | R4 | NetworkTypeVS | Network Type VS | active | 2024-10 | us | fhir |
hl7.fhir.us.davinci-pdex-plan-net | R4 | NonIndividualSpecialtiesVS | Non-Individual Specialties | active | 2024-10 | us | nucc |
hl7.fhir.us.davinci-pdex-plan-net | R4 | NonIndividualSpecialtyAndDegreeLicenseCertificateVS | Non-Individual Specialties, Degrees, Licenses, and Certificates VS | active | 2024-10 | us | fhir tho |
hl7.fhir.us.davinci-pdex-plan-net | R4 | OrgTypeVS | Organization Type VS | active | 2024-10 | us | fhir |
hl7.fhir.us.davinci-pdex-plan-net | R4 | OrganizationAffiliationRoleVS | OrganizationAffiliation Roles | active | 2024-10 | us | fhir |
hl7.fhir.us.davinci-pdex-plan-net | R4 | PractitionerRoleVS | PractitionerRole Code VS | active | 2024-10 | us | fhir tho |
hl7.fhir.us.davinci-pdex-plan-net | R4 | QualificationStatusVS | Qualification Status VS | active | 2024-10 | us | fhir |
hl7.fhir.us.davinci-pdex-plan-net | R4 | SpecialtiesVS | Specialties VS | active | 2024-10 | us | fhir nucc |
hl7.fhir.us.davinci-pdex-plan-net | R4 | SpecialtyAndDegreeLicenseCertificateVS | Specialties, Degrees, Licenses, and Certificates VS | active | 2024-10 | us | fhir tho |
hl7.fhir.us.davinci-pdex-plan-net | R4 | VirtualModalitiesVS | Virtual Modalities VS | active | 2024-10 | us | fhir |
hl7.fhir.us.odh | R4 | obf-datatype-YesNoVS | Yes No VS | draft | 2020-01 | us | |
hl7se.fhir.base | R4 | SEBaseAddressPersonVS | SE ValueSet for official address types | draft | 2024-10 | se | sct |
hl7se.fhir.base | R4 | SEBaseHOSPLegitimationsYrkeVS | SEBaseHOSPLegitimationsYrkeVS | draft | 2024-10 | se | oid |
hl7se.fhir.base | R4 | SEBaseHSABefattningVS | SEBaseHSABefattningVS | draft | 2024-10 | se | oid |
hl7se.fhir.base | R4 | SEBaseHSAVerksamhetVS | SEBaseHSAVerksamhetVS | draft | 2024-10 | se | oid |
hl7se.fhir.base | R4 | SEBaseMaritalStatusVS | SE ValueSet for marital status | draft | 2024-10 | se | internal tho |
hl7se.fhir.base | R4 | SEBaseNamePartQualifierVS | SE ValueSet for preferred name | draft | 2024-10 | se | tho |
hl7se.fhir.base | R4 | SEBaseSKRYrkeSpecialtyVS | SEBaseSKRYrkeSpecialtyVS | draft | 2024-10 | se | sct |
hl7se.fhir.base | R4 | SEBaseSKRYrkeVS | SEBaseSKRYrkeVS | draft | 2024-10 | se | sct |
hl7se.fhir.base | R4 | SEBaseSOSNYKVS | SEBaseSOSNYKVS | draft | 2024-10 | se | oid |
hl7se.fhir.base | R4 | SecurityLabelVS | SE ValueSet security labels | draft | 2024-10 | se | internal tho |
hl7.fhir.be.etariff | R4 | be-vs-etariffErrors | eTariff errors | draft | 2024-10 | be | internal |
hl7.fhir.be.etariff | R4 | be-vs-etarifftypes | eTariff types | draft | 2024-10 | be | internal |
hl7.fhir.be.etariff | R4 | be-vs-refusal-values | BeVSRefusalValues | draft | 2024-10 | be | internal |
hl7.eu.fhir.pcsp | R4 | ChemoUnitsVs | Chemotherapy cumulative dose units | draft | 2024-09 | eu | ucum |
hl7.eu.fhir.pcsp | R4 | activeResolved-condition-vs | Active or resolved Condition | draft | 2024-09 | eu | tho |
hl7.eu.fhir.pcsp | R4 | annotation-type-vs | Annotation type | draft | 2024-09 | eu | internal |
hl7.eu.fhir.pcsp | R4 | cond-test-vs | Conditions: follow up | draft | 2024-09 | eu | tho |
hl7.eu.fhir.pcsp | R4 | drugsAtc-eu-pcsp | Antineoplastic and immunostimulating agents | draft | 2024-09 | eu | atc |
hl7.eu.fhir.pcsp | R4 | grade-test-vs | Grade: follow up | draft | 2024-09 | eu | sct |
hl7.eu.fhir.pcsp | R4 | laterality-qualifier-lrub-vs | Laterality Qualifier Value Set | draft | 2024-09 | eu | sct tho |
hl7.eu.fhir.pcsp | R4 | mcode-body-location-qualifier-vs | Body Location Qualifier Value Set | draft | 2024-09 | eu | sct |
hl7.eu.fhir.pcsp | R4 | mcode-cancer-stage-group-vs | Stage Group Value Set | draft | 2024-09 | eu | |
hl7.eu.fhir.pcsp | R4 | mcode-cancer-staging-system-vs | Cancer Staging System Value Set | draft | 2024-09 | eu | sct |
hl7.eu.fhir.pcsp | R4 | mcode-observation-codes-distant-metastases-vs | Observation Codes for Distant Metastases Category | draft | 2024-09 | eu | loinc |
hl7.eu.fhir.pcsp | R4 | mcode-observation-codes-primary-tumor-vs | Observation Codes for Primary Tumor Category | draft | 2024-09 | eu | loinc |
hl7.eu.fhir.pcsp | R4 | mcode-observation-codes-regional-nodes-vs | Observation Codes for Regional Node Category | draft | 2024-09 | eu | loinc |
hl7.eu.fhir.pcsp | R4 | mcode-observation-codes-stage-group-vs | Observation Codes for Stage Group Category | draft | 2024-09 | eu | loinc |
hl7.eu.fhir.pcsp | R4 | mcode-tnm-distant-metastases-category-vs | TNM Distant Metastases Category Value Set | draft | 2024-09 | eu | |
hl7.eu.fhir.pcsp | R4 | mcode-tnm-primary-tumor-category-vs | TNM Primary Tumor Category Value Set | draft | 2024-09 | eu | |
hl7.eu.fhir.pcsp | R4 | mcode-tnm-regional-nodes-category-vs | TNM Regional Nodes Category Value Set | draft | 2024-09 | eu | |
hl7.eu.fhir.pcsp | R4 | morphologicAbnormality-eu-vs | Morphologically abnormal structure | draft | 2024-09 | eu | sct |
hl7.eu.fhir.pcsp | R4 | otherInfos-condition-vs | Other Infors Condition | draft | 2024-09 | eu | sct |
hl7.eu.fhir.pcsp | R4 | relapse-type-vs | Relapse type (Local/Distant/Combined) | draft | 2024-09 | eu | sct |
hl7.eu.fhir.pcsp | R4 | toxicityseverity-vs | Toxicity Severity | draft | 2024-09 | eu | fhir tho |
hl7.eu.fhir.pcsp | R4 | vs-Gvhd-acute-grade-eu-pcsp | Acute Gvhd Grade | draft | 2024-09 | eu | internal tho |
hl7.eu.fhir.pcsp | R4 | vs-Gvhd-chronic-grade-eu-pcsp | Chronic Gvhd condition | draft | 2024-09 | eu | internal tho |
hl7.eu.fhir.pcsp | R4 | vs-Gvhd-type-eu-pcsp | Gvhd condition | draft | 2024-09 | eu | internal sct |
hl7.eu.fhir.pcsp | R4 | vs-ProsthesisType-eu-pcsp | Prosthesis Type | draft | 2024-09 | eu | internal tho |
hl7.eu.fhir.pcsp | R4 | vs-ProstheticProcedureType-eu-pcsp | Prosthetic Surgical Procedure Type | draft | 2024-09 | eu | sct |
hl7.eu.fhir.pcsp | R4 | vs-action-eu-pcsp | Surgical Actions | draft | 2024-09 | eu | internal sct |
hl7.eu.fhir.pcsp | R4 | vs-affectedOrgan-eu-pcsp | Affected Organs (surgery) | draft | 2024-09 | eu | internal sct |
hl7.eu.fhir.pcsp | R4 | vs-amputationProcedureType-eu-pcsp | Amputation Surgical Procedure Type | draft | 2024-09 | eu | sct |
hl7.eu.fhir.pcsp | R4 | vs-brachytherapyType-eu-pcsp | Brachytherapy Type | draft | 2024-09 | eu | internal |
hl7.eu.fhir.pcsp | R4 | vs-calcest-eu-pcsp | Calculated|Estimated | draft | 2024-09 | eu | sct tho |
hl7.eu.fhir.pcsp | R4 | vs-colostomyProcedureType-eu-pcsp | Colostomy Surgical Procedure Type | draft | 2024-09 | eu | sct |
hl7.eu.fhir.pcsp | R4 | vs-docref-doctype-eu-pcsp | Document Type | draft | 2024-09 | eu | internal loinc |
hl7.eu.fhir.pcsp | R4 | vs-flt-plan-type-eu-pcsp | FLT Plan Type | draft | 2024-09 | eu | internal tho |
hl7.eu.fhir.pcsp | R4 | vs-fromToPosteriorAnterior-eu-pcsp | Body Location Qualifier Value Set | draft | 2024-09 | eu | internal sct |
hl7.eu.fhir.pcsp | R4 | vs-gastrostomyProcedureType-eu-pcsp | Gastrostomy Surgical Procedure Type | draft | 2024-09 | eu | sct |
hl7.eu.fhir.pcsp | R4 | vs-hereditary-eu-pcsp | Hereditary Predispositions or Disease | draft | 2024-09 | eu | sct |
hl7.eu.fhir.pcsp | R4 | vs-iccc3-eu-pcsp | ICCC-3 | draft | 2024-09 | eu | internal tho |
hl7.eu.fhir.pcsp | R4 | vs-icd10-predisposition-eu-pcsp | Hereditary Predispositions (ICD10) | draft | 2024-09 | eu | tho icd |
hl7.eu.fhir.pcsp | R4 | vs-icdo3-morphology-eu-pcsp | ICD-O-3 Morphology | draft | 2024-09 | eu | tho |
hl7.eu.fhir.pcsp | R4 | vs-icdo3-topography-eu-pcsp | ICD-O-3 Topography | draft | 2024-09 | eu | tho |
hl7.eu.fhir.pcsp | R4 | vs-isotopes-eu-pcsp | Radiotherapy Isotopes | draft | 2024-09 | eu | internal sct |
hl7.eu.fhir.pcsp | R4 | vs-naunk-eu-pcsp | Not Applicable|Unknown | draft | 2024-09 | eu | tho |
hl7.eu.fhir.pcsp | R4 | vs-npunk-eu-pcsp | Not Performed|Unknown | draft | 2024-09 | eu | tho |
hl7.eu.fhir.pcsp | R4 | vs-orpha-predisposition-eu-pcsp | Hereditary Predispositions (Orphacode) | draft | 2024-09 | eu | tho |
hl7.eu.fhir.pcsp | R4 | vs-othUnkTxt-eu-pcsp | Other/Unknown/Text | draft | 2024-09 | eu | tho |
hl7.eu.fhir.pcsp | R4 | vs-radiotherapy-pcsp | Radiotherapy sites | draft | 2024-09 | eu | internal tho |
hl7.eu.fhir.pcsp | R4 | vs-radiotherapyDeviceType-eu-pcsp | Radiotherapy Device Type | draft | 2024-09 | eu | internal |
hl7.eu.fhir.pcsp | R4 | vs-radiotherapyDoseType-eu-pcsp | Radiotherapy Dose Type | draft | 2024-09 | eu | sct dcm |
hl7.eu.fhir.pcsp | R4 | vs-radiotherapyDoseUnit-eu-pcsp | Radiotherapy dose units | draft | 2024-09 | eu | ucum |
hl7.eu.fhir.pcsp | R4 | vs-radiotherapyType-eu-pcsp | Radiotherapy Type | draft | 2024-09 | eu | sct tho |
hl7.eu.fhir.pcsp | R4 | vs-recommendation-eu-pcsp | Recommendations | draft | 2024-09 | eu | internal |
hl7.eu.fhir.pcsp | R4 | vs-riskcondition-eu-pcsp | Conditions at risk | draft | 2024-09 | eu | internal |
hl7.eu.fhir.pcsp | R4 | vs-riskfactor-eu-pcsp | Risk Factors | draft | 2024-09 | eu | internal |
hl7.eu.fhir.pcsp | R4 | vs-roa-eu-pcsp | Route of administration | draft | 2024-09 | eu | |
hl7.eu.fhir.pcsp | R4 | vs-sacrifiedOrgan-eu-pcsp | Sacrified Organs (surgery) | draft | 2024-09 | eu | internal sct |
hl7.eu.fhir.pcsp | R4 | vs-sct-donorType-eu-pcsp | Stem Cell Donor type | draft | 2024-09 | eu | internal |
hl7.eu.fhir.pcsp | R4 | vs-sct-prophylaxis-cathegory-eu-pcsp | SCT Prophylaxis Cathegory | draft | 2024-09 | eu | sct |
hl7.eu.fhir.pcsp | R4 |